Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer

Digestive Diseases and Sciences

Volumn 54, Issue 12, 2009, Pages 2655-2662

  Ma, Yan Lei ^a   Qin, Huan Long ^a   Liu, Wei Jie ^a   Peng, Jia Yuan ^a   Huang, Long ^a   Zhao, Xiao Ping ^b   Cheng, Yi Yu ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Metabolomics; PLS DA; UPLC MS

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MALE; METABOLITE; METABOLOMICS; MOLECULAR WEIGHT; PATTERN RECOGNITION; PILOT STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS; VOLUNTEER;

AGED; CASE-CONTROL STUDIES; CHINA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLECTOMY; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEAST-SQUARES ANALYSIS; MALE; METABOLOMICS; MIDDLE AGED; MOLECULAR WEIGHT; PATTERN RECOGNITION, AUTOMATED; PILOT PROJECTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 70450253541     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0665-4     Document Type: Article

References (24)

1. KE Hung DC Chung 2006 Colorectal cancer screening: today and tomorrow South Med J 99 3 240 246 10.1097/01.smj.0000203817.89741.29 10.1097/01.smj. 0000203817.89741.29 16553098
2. WC You F Jin S Devesa, et al. 2002 Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes J Cancer Epidemiol Prev 7 3 143 146 12665213
3. Sorensen N Moller Sorensen I Vejgaard Wurtz S Ornbjerg, et al. 2008 Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment Scand J Gastroenterol 43 7 774 786 10.1080/00365520701878163 10.1080/00365520701878163 (Pubitemid 351918510)
4. JC Lindon E Holmes ME Bollard, et al. 2004 Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis Biomarkers 9 1 1 31 10.1080/13547500410001668379 10.1080/13547500410001668379 1:CAS:528:DC%2BD2cXkt12ms7s%3D 15204308 (Pubitemid 38660013)
5. A Saghatelian BF Cravatt 2005 Global strategies to integrate the proteome and metabolome Curr Opin Chem Biol 9 1 62 68 10.1016/j.cbpa.2004.12.004 10.1016/j.cbpa.2004.12.004 1:CAS:528:DC%2BD2MXhtV2ksrY%3D 15701455 (Pubitemid 40208626)
6. JL Griffin 2006 Understanding mouse models of disease through metabolomics Curr Opin Chem Biol 10 4 309 315 10.1016/j.cbpa.2006.06.027 10.1016/j.cbpa.2006.06.027 1:CAS:528:DC%2BD28XntlGitLY%3D 16815732 (Pubitemid 44080657)
7. I Nobeli JM Thornton 2006 A bioinformatician's view of the metabolome Bioessays 28 5 534 545 10.1002/bies.20414 10.1002/bies.20414 1:CAS:528:DC%2BD28XkvVyjsLg%3D 16615085 (Pubitemid 43668068)
8. JL Griffin ME Bollard 2004 Metabonomics: its potential as a tool in toxicology for safety assessment and data integration Curr Drug Metab 5 5 389 398 10.2174/1389200043335432 10.2174/1389200043335432 1:CAS:528: DC%2BD2cXnvFars7Y%3D 15544433 (Pubitemid 39276603)
9. A J, Trygg J, Gullberg J, et al. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem. 2005;77(24):8086-8094.
10. E Thysell E Pohjanen J Lindberg, et al. 2007 Reliable profile detection in comparative metabolomics OMICS 11 2 209 224 10.1089/omi.2007.0006 10.1089/omi.2007.0006 1:CAS:528:DC%2BD2sXmvFKnurw%3D 17594239 (Pubitemid 47016181)
11. K Nicholson JC Lindon E Holm 1999 Metabonomics: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 11 1181 1189 10.1080/004982599238047 10.1080/004982599238047 1:CAS:528:DyaK1MXns12ms7k%3D 10598751
12. JL Griffin RA Kauppinen 2007 Tumour metabolomics in animal models of human cancer J Proteome Res 6 2 498 505 10.1021/pr060464h 10.1021/pr060464h 1:CAS:528:DC%2BD28Xht1GjsbfI 17269706 (Pubitemid 46340153)
13. O Beckonert HC Keun TM Ebbels, et al. 2007 Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts Nat Protocols 2 11 2692 2703 10.1038/nprot.2007.376 10.1038/nprot.2007.376 1:CAS:528:DC%2BD2sXhtlSlsr3E
14. T Kind V Tolstikov O Fiehn, et al. 2007 A comprehensive urinary metabolomic approach for identifying kidney cancerr Anal Biochem 363 2 185 195 10.1016/j.ab.2007.01.028 10.1016/j.ab.2007.01.028 1:CAS:528:DC%2BD2sXjsVWiurc%3D 17316536 (Pubitemid 46428214)
15. G Lu JS Wang XJ Zhao, et al. 2006 Study on gender difference based metabolites in urine by ultra high performance liquid chromatography/time of flight mass spectrometry Chin J Chromatogr 24 2 109 113 10.1016/S1872-2059(06) 60005-9 10.1016/S1872-2059(06)60005-9 1:CAS:528:DC%2BD28XjsFKhsbc%3D (Pubitemid 43963872)
16. ID Wilson JK Nicholson J Castro-Perez, et al. 2005 High resolution "ultra performance" liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies J Proteome Res 4 2 591 598 10.1021/pr049769r 10.1021/pr049769r 1:CAS:528:DC%2BD2MXisV2js7g%3D 15822939 (Pubitemid 40548168)
17. EG Stanley NJ Bailey ME Bollard, et al. 2005 Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance- based metabonomics Anal Biochem 343 2 195 202 10.1016/j.ab.2005.01.024 10.1016/j.ab.2005.01.024 1:CAS:528:DC%2BD2MXmvVWltrc%3D 15993369 (Pubitemid 41074031)
18. RS Plumb JH Granger CL Stumpf, et al. 2005 A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice Analyst (Lond) 130 6 844 849 10.1039/b501767j 10.1039/b501767j 1:CAS:528:DC%2BD2MXktlKru7w%3D PMID: 10598751 (Pubitemid 40880105)
19. YF Zheng GW Xu DY Liu, et al. 2002 Study of urinary nucleosides as biological marker in cancer patients analyzed by Micellar Electrokinetic Chromatography Electrophoresis 23 4104 4109 10.1002/elps.200290027 10.1002/elps.200290027 1:CAS:528:DC%2BD3sXlsVKitA%3D%3D 12481266 (Pubitemid 36131464)
20. B Perroud J Lee N Valkova 2006 Pathway analysis of kidney cancer using proteomics and metabolic profiling Mol Cancer 5 64 10.1186/1476-4598-5-64 10.1186/1476-4598-5-64 17123452 (Pubitemid 44941442)
21. C Schmidt 2004 Metabolomics takes its place as latest up-and-coming "omic" science J Natl Cancer Inst 96 10 732 734 15150298
22. K Dettmer BD Hammock 2004 Metabolomics: A new exciting weld within the "omics" sciences Environ Health Perspect 112 A396 A397 15159211
23. SA Wren 2005 Peak capacity in gradient ultra performance liquid chromatography (UPLC) J Pharm Biomed Anal 38 2 337 343 10.1016/j.jpba.2004.12. 028 10.1016/j.jpba.2004.12.028 1:CAS:528:DC%2BD2MXltVegt70%3D 15925228 (Pubitemid 40733163)
24. R Plumb J Castro-Perez J Granger, et al. 2004 Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry Rapid Commun Mass Spectrom 18 19 2331 2337 10.1002/rcm.1627 10.1002/rcm.1627 1:CAS:528:DC%2BD2cXot1Cmsbg%3D 15384155 (Pubitemid 39297371)